about
B cells with regulatory properties in transplantation toleranceTreatment of allergic asthma: modulation of Th2 cells and their responsesBlockade of the B7-H1/PD-1 pathway for cancer immunotherapyControl of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection.RGMb is a novel binding partner for PD-L2 and its engagement with PD-L2 promotes respiratory toleranceEnhanced upper genital tract pathologies by blocking Tim-3 and PD-L1 signaling pathways in mice intravaginally infected with Chlamydia muridarum.Lack of PD-L1 expression by iNKT cells improves the course of influenza A infection.Gene set signature of reversal reaction type I in leprosy patients.L2pB1: a new player in autoimmunity.Multiple mechanisms of immune suppression by B lymphocytesLabel-free quantification and shotgun analysis of complex proteomes by one-dimensional SDS-PAGE/NanoLC-MS: evaluation for the large scale analysis of inflammatory human endothelial cellsProgrammed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivityBiliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.Possible Noninvasive Biomarker of Eosinophilic Esophagitis: Clinical and Experimental Evidence.A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigensCirculating T lymphocyte subsets, cytokines, and immune checkpoint inhibitors in patients with bipolar II or major depression: a preliminary study.Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen.Clinical view on the importance of dendritic cells in asthma.Dendritic cells revisited in human allergic rhinitis and asthma.Blomia tropicalis allergen 5 (Blo t 5) T-cell epitopes and their ability to suppress the allergic immune response.PDCD1 PD-1.3 polymorphism and allergic bronchial asthma in Russian and Buryat patients.Searching for distinct mechanisms in eosinophilic and noneosinophilic airway inflammation.PD-1 blockage delays murine squamous cell carcinoma development.Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure.Impaired ICOSL in human myeloid dendritic cells promotes Th2 responses in patients with allergic rhinitis and asthma.Differential regulation of PD-1 and its ligands in allergic asthma.Programmed cell death-1 expression correlates with disease severity and IL-5 in chronic rhinosinusitis with nasal polyps.Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta.Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Between Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells.PD-1 has a unique capacity to inhibit allergen-specific human CD4 T cell responses
P2860
Q26771404-8B877677-C234-4F73-BD78-86607C5EB5BCQ27011823-12CE2404-AF57-4D07-B950-FD093D338DCEQ28394869-65DDBD72-6B17-48A3-8DC4-FED1A784747DQ30301182-281DEC67-37B6-4443-8CD2-8B86765BB0D9Q33569814-1BB7A706-BB50-472B-AC5A-622E3CD253C8Q34100837-21DA9462-D06D-4DD6-8A4E-1D9EB41D4B22Q34649276-6E84029E-802A-4EFD-B9AC-DE718BD1D5AFQ34845804-7985F2E7-EDC5-4D2E-9034-DAE690269640Q34927610-24F8579F-0270-48FD-8E73-8F975812A769Q35747533-A66FBBBD-BFB2-4E9C-8A11-F3A02D2E77A2Q36144197-704A888E-4B5F-484E-B699-F1D3142C5044Q36837356-233A825B-F365-4D1D-B26F-A4F7A11A2F77Q37176323-41460AEB-5589-49BE-8676-BB19D6AF656BQ37406571-E06B037F-FEE3-4F18-B6CE-C8781CAE3515Q37449004-027E7A19-D57E-47A3-BE48-39F2A93FE24DQ37491277-9F83E890-22EE-4F08-B034-6EAA7E269617Q37578777-C6172B3F-F5E4-4B95-A05A-0FE86AECCE49Q37740679-70502ABF-949B-4690-BB0E-B07946CA2BBDQ38152817-C554B652-CC64-4B17-A5A6-DB2E9522B2E1Q38596794-90EA7949-87C7-4609-B01C-6FEEB6D8506AQ39601232-7ECABF17-FC10-4F7C-972B-8A6F70D657AFQ40708051-0AB13322-91CE-4799-ABC6-A06A534F888CQ42968459-C6B85D99-2FF0-4758-AE04-5BF59C7521AFQ44360014-FE13EEAA-6333-441D-9DE5-1191E4FF0FE4Q46037111-52E57FC6-E183-4A28-815E-FE83E2639567Q46086504-F6A9ADA8-7888-4412-9AEC-B0814232E8E1Q48136496-00A8D85F-14C7-44F2-9E31-399738FEF03EQ48312642-1A8B71AD-E950-4913-8DFC-155D7D09D422Q54308278-126BFA7B-C497-4F5F-B9F1-3B3B738FD102Q55329379-0B6FEF82-E64D-4E8B-9440-62698D36BA26Q56889052-31BF4329-0D3E-4BCC-B469-0B53924EC04A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of PD-L1 and PD-L2 in allergic diseases and asthma
@en
Role of PD-L1 and PD-L2 in allergic diseases and asthma.
@nl
type
label
Role of PD-L1 and PD-L2 in allergic diseases and asthma
@en
Role of PD-L1 and PD-L2 in allergic diseases and asthma.
@nl
prefLabel
Role of PD-L1 and PD-L2 in allergic diseases and asthma
@en
Role of PD-L1 and PD-L2 in allergic diseases and asthma.
@nl
P2093
P2860
P1433
P1476
Role of PD-L1 and PD-L2 in allergic diseases and asthma
@en
P2093
P2860
P304
P356
10.1111/J.1398-9995.2010.02458.X
P577
2010-08-17T00:00:00Z